Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia.

Yazed Sulaiman H Al-Ruthia Othman R Alharbi Abdulrahman M Aljebreen Nahla Ali Azzam Majid Abdularahman Almadi Ohud H Bahari Khalid A Almalki Abdulaziz T Atham Ahmed S Alanazi Maria Saeed Baraa HajkhderMullaissa Mohammad Alsenaidy Bander Balkhi

Published in: Cost effectiveness and resource allocation : C/E (2019)

Biologics are extensively used in the management of IBD, particularly CD, and their utilization costs are significantly higher than non-biologics. Future studies should examine the cost effectiveness of IBD medications especially in countries with increasing incidence such as Saudi Arabia.

Keyphrases

saudi arabia
ulcerative colitis
risk factors
case control
drug induced